Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms (Q43207813)

16 November 2017

title

Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms (English)

1 reference

16 November 2017

Morris Schweitzer

1

1 reference

16 November 2017

Benjamin Mitmaker

2

1 reference

16 November 2017

Daniel Obrand

3

1 reference

16 November 2017

Nathan Sheiner

4

1 reference

16 November 2017

Cherrie Abraham

5

1 reference

16 November 2017

Stevan Dostanic

6

1 reference

16 November 2017

Melissa Meilleur

7

1 reference

16 November 2017

Tomoko Sugahara

8

1 reference

16 November 2017

Lorraine E Chalifour

9

1 reference

16 November 2017

publication date

23 December 2009

1 reference

Vascular and Endovascular Surgery

16 November 2017

published in

1 reference

16 November 2017

volume

44

1 reference

16 November 2017

issue

2

1 reference

16 November 2017

page(s)

116-122

1 reference

Abdominal aortic aneurysms: basic mechanisms and clinical implications

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Simvastatin suppresses experimental aortic aneurysm expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Statin Use Is Associated with Reduced All-Cause Mortality after Endovascular Abdominal Aortic Aneurysm Repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Plaque-Stabilizing Effect of Pitavastatin in Watanabe Heritable Hyperlipidemic(WHHL) Rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Anti-cancer therapy: targeting the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Matrix metalloproteinases and the regulation of tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Severe structural damage of the seemingly non-diseased infrarenal aortic aneurysm neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Simvastatin Attenuates the Activity of Matrix Metalloprotease-9 in Aneurysmal Aortic Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Associations between statin treatment and markers of inflammation, vasoconstriction, and coagulation in patients with abdominal aortic aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Extracellular control of TGFbeta signalling in vascular development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Aneurysm syndromes caused by mutations in the TGF-beta receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1538574409348352

21 January 2018

Identifiers

DOI

10.1177/1538574409348352

1 reference

16 November 2017

1 reference